NEW YORK – Genomic Testing Cooperative (GTC) began a program on Tuesday to address disparities in access to precision medicine for minority, low-income, or LGBTQ patients by offering free molecular profiling for cancer patients who may not have insurance that covers testing.
GTC will donate 5 percent of its annual testing volume to the program. The company will offer comprehensive molecular profiling (DNA and RNA) to patients nominated by their physicians. GTC will also help physicians determine the best treatment for their patients or help enroll them in clinical trials.